Yes — And Most GLP-1 Prescriptions Start in Primary Care

A common misconception is that you need to see an endocrinologist, obesity medicine specialist, or some other specialist to get a GLP-1 prescription. In reality, any licensed physician, nurse practitioner, or physician assistant who is authorized to prescribe medications in your state can prescribe GLP-1s. Your primary care provider (PCP) is often the best starting point.

Primary care physicians prescribe the majority of GLP-1 medications in the United States. They're already familiar with your medical history, current medications, and health goals — all of which are relevant to determining whether a GLP-1 is appropriate for you.

What Your PCP Evaluates

When you discuss GLP-1 medications with your primary care doctor, they'll assess several factors. They'll calculate your BMI and review your weight history over time. They'll evaluate any weight-related conditions such as diabetes, prediabetes, hypertension, or sleep apnea. They'll review your current medications for potential interactions. They'll check for contraindications including a personal or family history of medullary thyroid carcinoma, pancreatitis history, or MEN2 syndrome. And they'll discuss your treatment goals and expectations.

Most PCPs are comfortable prescribing GLP-1 medications — these drugs have been widely available since Ozempic's approval in 2017, and the clinical guidelines for prescribing them are well-established.

When a Specialist Might Help

While most patients can start and maintain GLP-1 therapy through primary care, there are situations where a specialist referral adds value. An endocrinologist may be helpful if you have complex diabetes management needs, thyroid conditions that require closer monitoring, or hormonal factors complicating your weight management. An obesity medicine specialist (certified by the American Board of Obesity Medicine) may offer more comprehensive programming that combines medication with nutrition counseling, behavioral therapy, and exercise guidance. A cardiologist may be relevant if you're pursuing GLP-1 therapy specifically for cardiovascular risk reduction, particularly in the context of the SELECT trial data showing semaglutide's benefits for heart attack and stroke prevention.

How to Start the Conversation

If you're interested in GLP-1 medication, bring it up directly. There's no need to be subtle or wait for your doctor to suggest it. A straightforward approach works well: tell your provider you've been researching GLP-1 medications for weight management, that you'd like to discuss whether you're a candidate, and ask what they'd recommend given your health history.

Come prepared with your weight history and any previous weight-loss attempts you've made, a list of your current medications and supplements, recent lab work if available (A1C, lipid panel, basic metabolic panel), and specific questions about the medications you're considering.

If your PCP isn't comfortable prescribing: Some primary care providers may not have extensive experience with GLP-1 medications or may prefer to refer out for weight management. This is reasonable — but it doesn't mean you can't access treatment. Ask for a referral to an obesity medicine specialist, or consider a telehealth platform where the prescribing providers specialize in these medications.

Primary Care vs. Telehealth for GLP-1s

Both pathways are legitimate. Your PCP offers the advantage of an established relationship, knowledge of your full medical history, and the ability to coordinate with your other care. Telehealth platforms offer convenience, often faster prescribing timelines, and providers who specialize specifically in GLP-1 prescribing.

For many patients, the best approach combines both: start with a conversation with your PCP, and if that pathway doesn't work out (they're uncomfortable prescribing, insurance is an obstacle, or you want faster access), explore telehealth as a complementary option. Your PCP can still monitor your overall health, lab work, and progress even if the GLP-1 prescription comes from a telehealth provider.

GLP-1 Prescribing Is Standard Medical Care

GLP-1 receptor agonists are not experimental or fringe treatments. They are FDA-approved, guideline-recommended medications with extensive clinical trial data supporting their safety and efficacy. The American Medical Association, the Endocrine Society, the American Academy of Family Physicians, and multiple other medical organizations support their use for eligible patients. Asking your doctor about them is no different from asking about blood pressure medication or cholesterol treatment — it's a conversation about evidence-based care for a documented medical condition.

Medical Disclaimer: This article is for informational purposes only and does not constitute medical advice. Always consult a licensed healthcare provider before starting, stopping, or changing any medication. GLP-1 receptor agonists are prescription medications with potential side effects and contraindications. Compounded medications are not FDA-approved. Pricing, coverage, and program details are subject to change—verify directly with providers and insurers.